IP Verse

Novartis Vaccines And Diagnostics competitive analysis

Latest patents of Novartis Vaccines And Diagnostics opposed by its competitors

Explore Novartis Vaccines And Diagnostics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP1801219
Oct 14, 2015Neisserial Antigenic Peptides1
EP2287192
Aug 26, 2015Methods For Preventing And Treating Cancer Metastasis And Bone Loss Associated With Cancer Metastasis3
EP1807116
May 6, 2015Influenza Vaccination1
EP2301546
Sep 10, 2014Treatment Of Metastasized Tumors1
EP2301572
Sep 10, 2014Cell-Derived Viral Vaccines With Low Levels Of Residual Cell Dna1
EP2327719
Aug 20, 2014Hybrid And Tandem Expression Of Neisserial Proteins1
EP2258716
Jul 16, 2014Multiple Variants Of Meningococcal Protein Nmb18701

Latest PTAB cases involving Novartis Vaccines And Diagnostics

Discover the latest PTAB cases involving Novartis Vaccines And Diagnostics, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 2, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Novartis Vaccines And Diagnostics

IPR2019-01086May 14, 2019REGENERON PHARMACEUTICALSNOVARTIS VACCINES AND DIAGNOSTICSTerminated

Peer Comparison New

IP litigation analysis comparing Novartis Vaccines And Diagnostics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NOVARTIS VACCINES AND DIAGNOSTICS - 9 - 1
FIVE PRIME THERAPEUTICS1 - - -
GLAXOSMITHKLINE BIOLOGICALS SA2910429
PFIZER761134412